Jeffrey Epstein, a science investor, has announced new findings in the study of late onset Alzheimer's disease. The research, conducted by Mount Sinai Hospital, the Icelandic Heart Association, Sage Bionetworks, and Merck Research Laboratories, identified genes related to brain inflammation that contribute to the disease. The study highlights the interaction between genes TYROBP and TREM2. Epstein, known for his involvement in mathematical approaches to medical research, emphasizes the potential for targeted therapies. He has been involved in various scientific and academic organizations.
documents/EFTA00583077.pdf
{}